Table 2 -.

All studies that evaluated decision aids designed for deciding between two or more medical (nonsurgery) treatments/screening options, by year and outcomes measured.

Medical versus medical decisions (n = 107)
Condition	Decision	Authors	Outcomes measured
			Knowledge	Perceived risk	Decisionalconflict	Satisfaction	Anxiety	Other
Breast cancer	Genetic testing	Lerman, 1997	√	√
		Green, 2001	√
		Green, 2004	√	√	√	√	√
		Miller, 2005	√	√
		Schwartz, 2001	√	√
		Wakefield, 2008a	√
		Wakefield, 2008b	√
	Mammogram	Mathieu, 2007	√		√		√
		Mathieu, 2010	√
		Baena-Canada, 2015	√
	Tamoxifen treatment	Fagerlin, 2011		√	√
		Ozanne, 2007	√
	Chemotherapy	Whelan, 2003	√			√
Colorectal cancer	Screening	Dolan, 2002	√		√
		Lewis, 2010						√
		Miller, 2011						√
		Pignone, 2000						√
		Ruffin, 2007						√
		Schroy, 2011	√			√
		Smith, 2010	√		√		√
		Steckelberg, 2011	√
		Trevena, 2008	√
		Wakefield, 2008	√		√
		Wolf, 2000		√
		Ferron, 2015						√
		Schroy, 2016				√
	Chemotherapy	Leighl, 2011	√		√		√
Congenital disorders	Prenatal testing	Bekker, 2004	√	√	√		√
		Bjorklund, 2012	√
		Kuppermann, 2009	√	√	√	√
		Kuppermann, 2014	√	√	√
		Nagle, 2008	√		√		√
		Hunter, 2005	√		√	√	√
		Leung, 2004						√
Dental conditions	Dental treatment	Johnson, 2006	√			√	√
		Kupke, 2003	√			√
Diabetes	Medication	Mann D, 2010		√	√
		Weymiller, 2007	√
		Mullan, 2009	√			√
		Mathers, 2012	√	√	√
	Screening	Mann E, 2010	√
	Lifestyle modifications	Marteau, 2010						√
Health behaviors	Smoking cessation	Warner, 2015						√
Cardiovascular disease	Stress testing	Hess, 2012	√
	Prevention of cardiovascular disease	Lalonde, 2006	√	√	√	√
		Sheridan, 2006						√
		Sheridan, 2011						√
	Preoperative autologous blood donation	Laupacis, 2006	√	√		√
	Antithrombotic therapy in atrial fibrillation	Man-Song-Hing, 1999	√		√	√
		McAlister, 2005						√
		Thomson, 2007						√
		Fraenkel, 2012	√		√
	Hypertension treatment	Montgomery, 2003						√
	Angiography access	Schwalm, 2012	√		√
Endocrine disorders	Hormone replacement therapy	Deschamps, 2004			√	√
		Dodin, 2001	√				√
		Legare, 2003			√
		McBride, 2002		√
		Murray, 2001			√		√
		O’Connor, 1998	√	√	√
		O’Connor, 1999		√
		Rostom, 2002						√
		Rothert, 1997						√
		Schapira, 2007	√		√	√
	Thyroid cancer	Sawka, 2012	√		√
Infectious diseases	Vaccinations	Chambers, 2012						√
		Clancy, 1988						√
		Shourie, 2013			√
	Antibiotics for respiratory infections	Legare, 2011			√
		Legare, 2012						√
Neurologic conditions	Feeding in dementia	Hanson, 2011	√		√
	Immunotherapy for multiple sclerosis	Kasper, 2008						√
Orthopedic conditions	Osteoarthritis	Fraenkel, 2007						√
	Osteoporosis	Montori, 2011		√
		LeBlanc, 2015	√	√	√
	Bisphosphonates use	Oakley, 2006						√
Prostate conditions	Prostate cancer screening	Allen, 2010	√		√
		Evans, 2010	√		√		√
		Frosch, 2008	√		√
		Gattellari, 2003	√		√
		Gattellari, 2005	√		√
		Krist, 2007	√		√
		Lepore, 2012	√		√		√
		Myers, 2005						√
		Myers, 2011	√		√
		Partin, 2004	√
		Rubel, 2010	√		√		√
		Schapira, 2000	√
		Taylor, 2006	√		√	√
		Volk, 1999	√
		Volk, 2008			√
		Watson, 2006	√
		Williams, 2013	√		√
		Wolf, 1996						√
Psychiatric conditions	Treatment of schizophrenia	Hamann, 2006						√
	Treatment of depression	Loh, 2007				√
	Treatment of PTSD	Mott, 2014						√
Women’s health	Contraceptives after abortion	Langston, 2010						√
	Natural health products in menopause	Legare, 2008	√		√
	Management of abnormal cervical smear	McCaffery, 2010					√
	Delivery post caesarian section	Montgomery, 2007			√
		Eden, 2014	√		√
	Management of breech presentation	Nassar, 2007	√		√	√	√
	Management of menorrhagia	Protheroe, 2007	√		√		√
	Labor analgesia	Raynes-Greenow, 2010	√		√		√
	Ovarian cancer risk management	Tiller, 2006	√		√	√	√
	Number of embryos implanted in IVF	Van Peperstraten, 2010	√				√